The right people to fight inflammation pipeline pain partners autoimmune diseases people

Solving unmet needs with a
proven track record.

We’re a dynamic company led by experienced leaders in the industry who are strategically building a portfolio with powerful opportunities in two emerging and growing categories: non-opioid pain relief and immunology.

Meet our industry-leading team, with a record of transformational drug development.

Management Team

Use the left and right arrow keys to access the carousel navigation buttons
Niti Goel, M.D.
Medical Advisor
Mike Ward
Mike Ward
Chief Financial Officer/Chief Operations Officer
SMITAL SHAH
Smital Shah
Acting CBO
Jonathan Guerriero
Jonathan Guerriero
Chief Development Operations Officer
Randall Stevens
Randall Stevens, M.D.
Chief Medical Officer
Jeffrey B. Kindler
Jeffrey B. Kindler
Chief Executive Officer
Sarah Kelly
Sarah Kelly
Vice President, Corporate Development
James Campbell
James N. Campbell, M.D.
President, Chief Scientific Officer
Niti Goel, M.D.
Medical Advisor
Mike Ward
Mike Ward
Chief Financial Officer/Chief Operations Officer
SMITAL SHAH
Smital Shah
Acting CBO
Jonathan Guerriero
Jonathan Guerriero
Chief Development Operations Officer
Randall Stevens
Randall Stevens, M.D.
Chief Medical Officer
Jeffrey B. Kindler
Jeffrey B. Kindler
Chief Executive Officer
Sarah Kelly
Sarah Kelly
Vice President, Corporate Development
James Campbell
James N. Campbell, M.D.
President, Chief Scientific Officer
Niti Goel, M.D.
Medical Advisor
Mike Ward
Mike Ward
Chief Financial Officer/Chief Operations Officer
Press escape to go to the first slide
Press escape to go to the first slide

Board of Directors

Use the left and right arrow keys to access the carousel navigation buttons
Jeffrey B. Kindler
Jeffrey B. Kindler
Chief Executive Officer
James Campbell
James N. Campbell, M.D.
President, Chief Scientific Officer
Colin Hill
Colin Hill
Director
J. Swedish
Joseph R. Swedish
Director
Shawn Tomasello
Shawn Tomasello
Director
Sol Barer, Ph.D.
Sol Barer, Ph.D.
Chairman
Jeffrey B. Kindler
Jeffrey B. Kindler
Chief Executive Officer
James Campbell
James N. Campbell, M.D.
President, Chief Scientific Officer
Colin Hill
Colin Hill
Director
J. Swedish
Joseph R. Swedish
Director
Shawn Tomasello
Shawn Tomasello
Director
Sol Barer, Ph.D.
Sol Barer, Ph.D.
Chairman
Jeffrey B. Kindler
Jeffrey B. Kindler
Chief Executive Officer
James Campbell
James N. Campbell, M.D.
President, Chief Scientific Officer
Colin Hill
Colin Hill
Director
J. Swedish
Joseph R. Swedish
Director
Press escape to go to the first slide
Press escape to go to the first slide

Our people, expertise, and pipeline position us for success.

With our strategic focus on key markets with unmet needs, Centrexion is ready to transform the ways in which pain and immunology are treated.

READ MORE

Pain — relief
without addiction

Immunology — harnessing
the body’s defenses

Use the left and right arrow keys to access the carousel navigation buttons
NIH
Sanofi
Lilly
Boehringer Ingelheim
NIH
Sanofi
Lilly
Boehringer Ingelheim
Press escape to go to the first slide
Press escape to go to the first slide

Explore our flexible partner path

Join our prestigious partners, such as Lilly, Boehringer Ingelheim, and NIH, in focusing on high-value markets with significant unmet need. We are poised to make meaningful headway, as governmental and private support for non-opioid pain drug development grows and we expand our commitment to the unlimited potential of new, broadband immunology medicines.

Back To Top